U.S. Markets closed

Apostle Inc Presents at the 7th Asia Pharma R&D Leaders 2017

SUNNYVALE, Calif., April 14, 2017 /PRNewswire-iReach/ -- Apostle Inc today led a round-table discussion at the 7th Asia Pharma R&D Leaders 2017, held in Shanghai, China.

"It's my pleasure to welcome our friends, colleagues, and business partners.  We hope leading executives from the industry can find this conference an opportunity to discuss key topics from global R&D trends, development strategies to collaboration opportunities," said Dr. Shoubai Chao, Senior Vice President of AstraZeneca leading the company's Bioventures Operations globally and specifically in China and other Asian countries. Dr. Chao is Chairman of the conference.

"Precision medicine has become part of the strategical focuses of the national healthcare policy in two of the world's largest economies – the U.S. and China. Precision medicine starts with precision diagnosis," said Dr. David Dongliang Ge, CEO & President of Apostle Inc, as he led a round-table discussion titled "Grasp the Key Trends and Focuses in Biotechnology Advancements", "China has about 20% of the global population.  Disproportionately, the nation's incidence of lung cancer is approximately 733,000 in 2015, contributing to around 40% of the new cases globally.  Technological advancements in early cancer detection can be a key in managing this enormous challenge."

"We believe the discovery and application of novel biomarkers and companion diagnostics play the key role in precision medicine and drug R&D," said Dr. Nick Zhang, CEO of Qiagen (Suzhou) Translational Medicine Co. Ltd.

Other speakers included Dr. Mingqiang Zhang, VP at Amgen and Head of Amgen Asia R&D Center located in Shanghai, China; Dr. Xun Zhu, Expert of National New Drug Advisory Committee of the CFDA; and Dr. Lianshan Zhang, VP of R&D at Jiangsu Hengrui Medicine, a leading pharmaceutical company in China.

About Apostle Inc

Apostle Inc is a biotechnology company in Sunnyvale, CA. It's in the business of the research, development, licensing, and sales of novel AI (Artificial Intelligence)-Enabled Nanotechnologies and the related intellectual properties, products, and services for diagnosis and treatment of human diseases.

About The 7th Asia Pharma R&D Leaders 2017

The 7th Asia Pharma R&D Leaders 2017, held on April 11-12 in Shanghai by the Shine Consultant International, is designed to be a premium strategic platform for big pharma, biotech, academia stakeholders to meet, communicate and establish a partnership on pharma R&D. Leading executives from the industry will discuss key topics from global R&D trends, development strategies, innovation capability building to collaboration opportunities.

Media Contact: Public Relations, Apostle, Inc, Apostle, Inc, 650-483-5437, pr@apostlebio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com